CINECA IRIS Institutional Research Information System

COSTELLI, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.555
EU - Europa 4.815
AS - Asia 3.461
OC - Oceania 164
SA - Sud America 152
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 22
Totale 15.214
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.405
CN - Cina 1.884
DE - Germania 1.160
IT - Italia 870
IE - Irlanda 597
FR - Francia 389
KR - Corea 347
SG - Singapore 328
FI - Finlandia 305
JP - Giappone 303
GB - Regno Unito 287
SE - Svezia 277
UA - Ucraina 256
VN - Vietnam 183
PL - Polonia 167
AU - Australia 156
CA - Canada 132
BR - Brasile 119
TW - Taiwan 111
ES - Italia 93
ID - Indonesia 68
HK - Hong Kong 66
BE - Belgio 61
NL - Olanda 61
AT - Austria 58
IN - India 55
CH - Svizzera 40
DK - Danimarca 39
RU - Federazione Russa 33
NO - Norvegia 32
TR - Turchia 26
PT - Portogallo 23
EU - Europa 21
GR - Grecia 21
MO - Macao, regione amministrativa speciale della Cina 17
MX - Messico 16
TH - Thailandia 16
ET - Etiopia 12
CL - Cile 11
SA - Arabia Saudita 11
CO - Colombia 10
HU - Ungheria 10
IR - Iran 10
SN - Senegal 10
IL - Israele 9
RO - Romania 9
AR - Argentina 8
NZ - Nuova Zelanda 8
MY - Malesia 7
NG - Nigeria 7
ZA - Sudafrica 6
BD - Bangladesh 5
CZ - Repubblica Ceca 4
BG - Bulgaria 3
EE - Estonia 3
NP - Nepal 3
RS - Serbia 3
SI - Slovenia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BW - Botswana 2
EG - Egitto 2
IQ - Iraq 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
MD - Moldavia 2
PK - Pakistan 2
ZM - Zambia 2
A1 - Anonimo 1
BT - Bhutan 1
CR - Costa Rica 1
CY - Cipro 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MT - Malta 1
NE - Niger 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
Totale 15.214
Salva come PNG Salva come JPEG
Città #
Beijing 723
Chandler 650
Dublin 580
Fairfield 475
Houston 414
Ann Arbor 301
Ashburn 296
Torino 259
Singapore 239
Wilmington 222
Villeurbanne 216
Princeton 208
Woodbridge 196
Cambridge 190
Medford 186
Jacksonville 185
Seattle 184
Hangzhou 171
Warsaw 152
Shanghai 148
Pisa 145
Redwood City 141
Nyköping 131
Dong Ket 111
Guangzhou 93
Dearborn 76
Nanjing 73
Taipei 67
Boston 65
Jakarta 58
Turin 56
Milan 53
Tokyo 51
Vienna 49
Chengdu 44
Toronto 44
Seoul 42
Nürnberg 40
Berlin 38
San Diego 37
Wuhan 36
Jinan 35
Rome 35
Norwalk 34
Boardman 33
Hefei 32
Santa Clara 32
Sydney 32
Fremont 30
Melbourne 28
Brussels 27
Munich 27
Brisbane 26
São Paulo 24
Changsha 23
Chicago 23
Shenyang 23
Chongqing 22
Columbia 22
Los Angeles 22
New York 22
Dallas 21
Verona 21
Barcelona 20
Falls Church 20
Helsinki 20
Madrid 20
Phoenix 20
Xian 20
Hong Kong 19
Duncan 17
Rochester 17
Silver Spring 17
Amsterdam 16
Columbus 16
Evanston 16
Central District 15
Copenhagen 15
Montréal 15
Zhengzhou 15
Central 14
Des Moines 14
Florence 14
San Jose 14
Xiamen 14
Indianapolis 13
London 13
Macao 13
Nanchang 13
Nottingham 13
Oslo 13
Ottawa 13
Washington 13
Bethesda 12
Hanoi 12
Hebei 12
Philadelphia 12
Durham 11
Kunming 11
Pittsburgh 11
Totale 8.592
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy 1.807
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 620
ß-hydroxy-ß-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia 442
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function 441
Coming back: autophagy in cachexia 439
Autophagic degradation contributes to muscle wasting in cancer cachexia 404
Novel investigational drugs mimicking exercise for the treatment of cachexia 401
JNK activation is required for TNFα-induced apoptosis in human hepatocarcinoma cells 299
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 253
Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression 237
Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by Tumor Necrosis Factor-alpha 222
MuRF-1 and p-GSK3β expression in muscle atrophy of liver cirrhosis 215
Mechanism-based therapeutic approaches to cachexia 204
Changes in myostatin signaling in non weight-losing cancer patients 199
Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations 196
Effect of the specific proteasome inhibitor Bortezomib on cancer-related muscle wasting 194
Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle 181
Autophagy is induced in the skeletal muscle of cachectic cancer patients 179
Combined approach to counteract experimental cancer cachexia: eicosapentenoic acid and training exercise 178
Role of Inflammation in Muscle Homeostasis and Myogenesis 173
Vitamin D and VDR in cancer cachexia and muscle regeneration 169
Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine 167
New developments in investigational HDAC inhibitors for the potential multimodal treatment of cachexia 156
Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy 155
Early changes of muscle IGF-1 and myostatin gene expression in gastric cancer patients 144
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival 139
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition 137
Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models 132
Interference with Ca 2+ -dependent proteolysis does not alter the course of muscle wasting in experimental cancer cachexia 125
In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by Taxol 124
CASPASE 2 ACTIVATION AND ER STRESS DRIVE RAPID JURKAT CELL APOPTOSIS BY CLOFIBRATE 122
Apoptosis induced by clofibrate in Yoshida AH-130 hepatoma cells: role of HMG-CoA reductase. 119
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice 117
Guidelines for the use and interpretation of assays for monitoring autophagy 116
Moderate exercise improves experimental cancer cachexia by modulating the redox homeostasis 116
Modulating metabolism to improve cancer-induced muscle wasting 110
Ca(2+)-dependent proteolysis in muscle wasting. 107
The Skeletal Muscle as an Active Player Against Cancer Cachexia 107
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 106
Anti-proliferative effects of an extra-virgin olive oil extract enriched in ligstroside aglycone and oleocanthal on human liver cancer cell lines 104
HGF receptor agonists protect cardiomyocytes from CoCl2-induced cell injury 103
Animal models for cancer cachexia 97
Cancer-induced muscle wasting: Latest findings in prevention and treatment 96
4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line 95
Circ-ZNF609: a novel regulator of myogenesis 95
Interleukin-4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma-bearing mice 91
Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature 88
Patogenesi dell'ipotrofia muscolare nella cachessia neoplastica: ruolo della via di segnalazione attivata da IGF-1 86
HGF receptor agonists protect cardiomyocytes from CoCl2-induced cell injury 82
A CircRNA/miR axis contributes to hypoxia-induced cardiomyocyte death 80
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 77
Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca2+-dependent proteolytic systems in the muscle of tumour-bearing rats 76
Beta-hydroxy-beta-methylbutyrate prevents weight and muscle loss in cancer cachexia 74
Differential modulation of TNf alpha-induced cell death by 3-methyladenine, an autophagy inhibitor 72
Ca2+-dependent apoptosis in Jurkat cells treated with clofibrate 72
La somministrazione di idrossi-metil-butirrato previene la perdita di peso e di muscolo in un modello sperimentale di cachessia neoplastica 71
Anticytokine strategies for the treatment of cancer-related anorexia and cachexia 70
Altered pattern of lipid metabolism in patients with lung cancer 70
Are there any benefits for exercise training in cancer cachexia? 69
Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia 68
Cancer cachexia: metabolic alterations and therapeutic approaches in an experimental model 68
Differential modulation of TNfα-induced cell death by 3-methyladenine, an autophagy inhibitor. 66
Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumorbearing c26 mice 66
Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? 65
Rapid and extensive lethal action of clofibrate on hepatoma cells in vitro 64
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice 64
Are antioxidants useful to treat skeletal muscle atrophy? 63
Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats 63
Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer-and chemotherapy-induced cachexia 63
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" 63
Alpha-adrenergic receptors may contribute to the hypertriglyceridemia associated with tumuor growth 62
Cancer cachexia: from experimental models to patient management 61
Alterations of lipid and cholesterol metabolism in cahectic tumor-bearing rats are prevented by insulin 61
Anti-TNF treatment interferes with changes in lipid metabolism in a tumour cachexia model 58
L'inibizione del sistema proteolitico ATP-ubiquitina dipendente non previene la perdita di massa muscolare in un modello sperimentale di cachessia neoplastica 57
Peroxisome proliferators induce apoptosis in hepatoma cells. 56
Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia 55
Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle 55
MODULATIONS OF MYOSTATIN IN CANCER CACHEXIA. 54
The calpain system is modulated in experimental cancer cachexia 53
Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models. 52
Mice lacking TNFa receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody 51
The cytosolic sialidase Neu2 is degraded by autophagy during myoblast atrophy 50
Tumour growth influences skeletal muscle protein turnover in the pregnant rat 49
PERTURBATIONS OF THE IGF-1 SYSTEM IN CANCER CACHEXIA 49
Effect of dehydroepiandrosterone in the prevention of cancer- and diabetes-induced cachexia 49
Statins, coenzyme Q10 and cachexia: what’s the link? 49
Protein kinases in the pathogenesis of muscle wasting 48
Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations 48
Combined Exercise Training Positively Affects Muscle Wasting in Tumor-bearing Mice 48
Strategies for Reducing Salt and Sugar Intakes in Individuals at Increased Cardiometabolic Risk 48
Myostatin blockade by deacetylase inhibitors fails to counteract muscle wasting in tumor-bearing mice 47
Interleukin-15 increases calcineurin expression in 3T3-L1 cells: possible involvement on in vivo adipocyte differentiation 46
Understanding the mechanisms of muscle wasting to improve the management of several pathologies 44
Skeletal muscle apoptosis is not increased in gastric cancer patients with mild-moderate weight loss 43
Nutritional support in cancer 43
Branched-chain amino acid catabolism and cancer cachexia 43
Effect of two aliphatic aldehydes, methylglyoxal and 4-hydroxypentenal, on the growth of Yoshida ascites hepatoma AH-130. 42
Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stress 42
MUSCLE IGF-1 GENE EXPRESSION IS DOWNREGULATED IN EXPERIMENTAL CANCER CACHEXIA 42
Totale 13.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.813
article - articoli 0
book - libri 0
conference - conferenze 3.743
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.068 0 0 149 311 192 281 256 179 245 185 165 105
2020/20211.674 137 113 157 91 135 95 132 93 153 181 116 271
2021/20221.887 85 92 109 137 152 137 132 114 82 128 314 405
2022/20232.483 310 197 97 207 232 574 189 127 272 53 125 100
2023/20241.466 158 206 110 117 115 114 94 99 33 119 106 195
2024/2025452 80 230 142 0 0 0 0 0 0 0 0 0
Totale 15.750